Endodontic Treatment of Primary Teeth With Guedes-Pinto Paste Without Antibiotic
Completed
University of Sao Paulo
Phase 3
2018-06-08
The pulp therapy in primary teeth is still necessary even with all odontopediatrics evolution
in prevention and minimal intervention, aiming to keep the tooth free of inflammation or
infection and in a functional state until its exfoliation. Several materials are used as
filling paste of primary teeth. In Brazil, the Guedes-Pinto Paste (PGP), an association of
iodofórmio, camphorated paramonochlorophenol, prednisolone and rifamycin, has been widely
used for some decades. However, current Brazilian legislation has made it difficult to
commercialize antibiotics, which has made it difficult to obtain the ointment that is the
association between prednisolone and rifamycin. Therefore, the objective of this clinical
trial will be to test PGP without rifamycin in the pulpectomy of primary teeth, and to
compare it with the treatment performed with conventional PGP.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
